CNBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.531800E-01
Normal-vs-Stage2
6.918000E-01
Normal-vs-Stage3
2.911400E-01
Normal-vs-Stage4
5.885800E-01
Stage1-vs-Stage2
6.347800E-01
Stage1-vs-Stage3
4.654400E-01
Stage1-vs-Stage4
9.661600E-02
Stage2-vs-Stage3
2.884200E-01
Stage2-vs-Stage4
2.578400E-01
Stage3-vs-Stage4
1.117630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.511600E-01
Normal-vs-AfricanAmerican
6.568800E-01
Normal-vs-Asian
4.761600E-01
Caucasian-vs-AfricanAmerican
8.653200E-01
Caucasian-vs-Asian
4.215000E-01
AfricanAmerican-vs-Asian
7.529200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.661400E-01
Normal-vs-Female
6.357800E-01
Male-vs-Female
9.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.410200E-01
Normal-vs-Age(41-60Yrs)
9.740000E-01
Normal-vs-Age(61-80Yrs)
4.671200E-01
Normal-vs-Age(81-100Yrs)
9.881800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.123400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.348800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.577200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.653750E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.827200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.935830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.012000E-01
Normal-vs-Daily Drinker
6.906200E-01
Normal-vs-Weekly Drinker
3.224800E-01
Normal-vs-Occasional Drinker
7.539600E-01
Normal-vs-Social Drinker
5.086400E-01
Non Drinker-vs-Daily Drinker
4.921200E-01
Non Drinker-vs-Weekly Drinker
6.572400E-01
Non Drinker-vs-Occasional Drinker
3.012200E-02
Non Drinker-vs-Social Drinker
8.091600E-01
Daily Drinker-vs-Weekly Drinker
3.647200E-01
Daily Drinker-vs-Occasional Drinker
1.813050E-01
Daily Drinker-vs-Social Drinker
7.242400E-01
Weekly Drinker-vs-Occasional Drinker
4.418000E-02
Weekly Drinker-vs-Social Drinker
5.633400E-01
Occasional Drinker-vs-Social Drinker
1.148430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.495400E-01
Normal-vs-Grade 2
7.623800E-03
Normal-vs-Grade 3
1.996390E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.355100E-03
Grade 1-vs-Grade 3
2.137600E-03
Grade 1-vs-Grade 4
2.495400E-01
Grade 2-vs-Grade 3
3.947200E-01
Grade 2-vs-Grade 4
7.623800E-03
Grade 3-vs-Grade 4
1.996390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.550800E-01
Normal-vs-NonDiabetic
5.437600E-01
Diabetic-vs-NonDiabetic
9.803200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.956000E-01
Normal-vs-NoPancreatitis
6.008800E-01
Pancreatitis-vs-NoPancreatitis
9.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.752200E-01
Normal-vs-N1
7.117600E-01
N0-vs-N1
5.332600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.863200E-01
Normal-vs-TP53-NonMutant
5.370400E-01
TP53-Mutant-vs-TP53-NonMutant
6.839700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
